ACCENTIA BIOPHARMACEUTICALS INC — Form D
ACCENTIA BIOPHARMACEUTICALS INC of TAMPA, FL, a company, filed a Form D exempt-offering notice with the SEC on 2012-02-08. The offering totals $5.0M, of which $400K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2012-02-08
- Form: D
- Accession: 0000897069-12-000152
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $5.0M
- Amount sold: $400K
- Remaining: $4.6M
- Investors: 1
- Date of first sale: 2012-01-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-173069
Issuer
- Name: ACCENTIA BIOPHARMACEUTICALS INC
- CIK: 0001310094
- Entity type: Corporation
- Jurisdiction: FLORIDA
- Address: 324 SOUTH HYDE PARK AVE, TAMPA, FL, 33606
- Phone: 813-864-2554
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Carlos F Santos | Executive Officer | Saint Louis, MO |
| David M Schubert | Director | Houston, TX |
| Francis E O'Donnell, Jr. | Director | Tampa, FL |
| Francis E O'Donnell, Jr. | Executive Officer | Tampa, FL |
| Douglas M Calder | Executive Officer | Tampa, FL |
| Garrison J Hasara | Executive Officer | Tampa, FL |
| Edmund C King | Director | Tampa, FL |
| James A McNulty | Executive Officer | Tampa, FL |
| William S Poole | Director | Tampa, FL |
| Samuel S Duffey | Executive Officer | Tampa, FL |
| Christopher C Chapman | Director | Tampa, FL |
Other filings by this issuer (1)
More